Understanding cell penetration of cyclic peptides

PG Dougherty, A Sahni, D Pei - Chemical Reviews, 2019 - ACS Publications
Approximately 75% of all disease-relevant human proteins, including those involved in
intracellular protein–protein interactions (PPIs), are undruggable with the current drug …

Cancer prevention and treatment using combination therapy with natural compounds

ER Sauter - Expert review of clinical pharmacology, 2020 - Taylor & Francis
Introduction: Naturally occurring compounds play an essential role in the prevention and
treatment of various cancers. There are more than 100 plant and animal based natural …

Bacteria as a treasure house of secondary metabolites with anticancer potential

CD Mohan, S Rangappa, SC Nayak… - Seminars in cancer …, 2022 - Elsevier
Cancer stands in the frontline among leading killers worldwide and the annual mortality rate
is expected to reach 16.4 million by 2040. Humans suffer from about 200 different types of …

[HTML][HTML] Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies

A Zhao, H Zhou, J Yang, M Li, T Niu - Signal Transduction and Targeted …, 2023 - nature.com
Hematologic malignancies are one of the most common cancers, and the incidence has
been rising in recent decades. The clinical and molecular features of hematologic …

[HTML][HTML] MYC competes with MiT/TFE in regulating lysosomal biogenesis and autophagy through an epigenetic rheostat

I Annunziata, D van de Vlekkert, E Wolf… - Nature …, 2019 - nature.com
Coordinated regulation of the lysosomal and autophagic systems ensures basal catabolism
and normal cell physiology, and failure of either system causes disease. Here we describe …

[HTML][HTML] Current methods of post-translational modification analysis and their applications in blood cancers

K Dunphy, P Dowling, D Bazou, P O'Gorman - Cancers, 2021 - mdpi.com
Simple Summary This review discusses current techniques used to study post-translational
protein modifications (PTMs) and their contribution to blood cancer research. Blood cancer …

[HTML][HTML] The role of protein acetylation in carcinogenesis and targeted drug discovery

J Yang, C Song, X Zhan - Frontiers in Endocrinology, 2022 - frontiersin.org
Protein acetylation is a reversible post-translational modification, and is involved in many
biological processes in cells, such as transcriptional regulation, DNA damage repair, and …

[HTML][HTML] Phase I/Ib study of tenalisib (RP6530), a dual PI3K δ/γ inhibitor in patients with relapsed/refractory T-cell lymphoma

A Huen, BM Haverkos, J Zain, R Radhakrishnan… - Cancers, 2020 - mdpi.com
Tenalisib (RP6530), a dual phosphoinositide 3-kinase δ/γ inhibitor was evaluated in a
phase I/Ib study for maximum tolerated dose (MTD), pharmacokinetics, and efficacy in …

Discovery of HDAC6-Selective Inhibitor NN-390 with in Vitro Efficacy in Group 3 Medulloblastoma

N Nawar, S Bukhari, AA Adile, Y Suk… - Journal of medicinal …, 2022 - ACS Publications
Histone deacetylase 6 (HDAC6) has been targeted in clinical studies for anticancer effects
due to its role in oncogenic transformation and metastasis. Through a second-generation …

Ultrasound‐Activatable g‐C3N4‐Anchored Titania Heterojunction as an Intracellular Redox Homeostasis Perturbator for Augmented Oncotherapy

M He, H Yu, Y Zhao, J Liu, Q Dong, Z Xu, Y Kang… - Small, 2023 - Wiley Online Library
Energy band structure of inorganic nano‐sonosensitizers is usually optimized by surface
decoration with noble metals or metal oxide semiconductors, aiming to enhance interfacial …